Aspect Biosystems
Regenerative Medicine
3 open rolesRegenerative MedicineVancouver, Canada100 employees$260M raisedEst. 2013
Dimension
Novo Nordisk
Radical Ventures
InBC
Pallasite Ventures
Pangaea Ventures
About Aspect Biosystems
- Aspect Biosystems is a biotechnology company pioneering the development of Bioprinted Tissue Therapeutics (BTTs) to transform how we treat some of the most elusive diseases.
- Their transformative platform technology integrates proprietary AI-powered bioprinting technology, computational design tools, and therapeutic cells to design tissues that replace, repair, or supplement biological function inside the body.
Aspect Biosystems is listed on Rocketlist with 3 active roles. The company is categorized as Regenerative Medicine in BioTech. Aspect Biosystems is at Series B stage, with a B2B business model, headquartered in Vancouver, Canada. Aspect Biosystems was founded in 2013 and has 100 employees. Aspect Biosystems has raised $260M. Active roles are refreshed daily from public hiring sources.